Petitioner Not Allowed To Use Joinder To Add New Issues To Instituted Inter Partes Review

Oct 2, 2014

Reading Time : 1 min

In two separate decisions, the Patent Trial and Appeal Board (the board) denied Target’s motion for joinder by a 3­2 vote and, denied institution of the inter partes review as being time­barred.

Joinder

Target previously had petitioned for inter partes review of the ‘563 patent. Target later filed another petition for the same patent and simultaneously moved to join the new proceeding with the already instituted IPR.

The board began by reviewing the joinder statute, which allows any person who properly files a petition to join an inter partes review, subject to the director’s discretion. The board interpreted the statute narrowly, finding that it only allows the joining of a person and not new issues in another petition. Because Target already was a party to the IPR proceeding, it could not be joined to that proceeding.

The dissent argued that the majority’s interpretation of 35 U.S.C. § 315(c) was nonsensical since the statute also require the joining party to file its own petition. The dissent also relied on the board’s prior rulings that consistently have allowed joinder of additional grounds by the same party. After presenting its own statutory construction analysis, the dissent determined that joinder of additional grounds by the same party is permissible.

Timeliness

The patent owner had served its patent infringement lawsuit on Target on October 4, 2012. Target filed the subject petition on March 14, 2014, more than one year after the Complaint. Under 35 U.S.C. § 315(c), the one year time bar does not apply to a person’s request to “join as a party to [a previously instituted] inter partes review.” Although Target moved for joinder, the board found that while the time bar does not apply to the party, it does apply to the petition. The dissent disagreed with the majority’s reading of the statute, believing that if joinder appropriate, the time bar would not apply.

Target Corp. v. Destination Maternity Corp., IPR2014­00508, Paper No. 18 (PTAB Sept. 25, 2014); Target Corp. v. Destination Maternity Corp., IPR2014­00508, Paper No. 20 (PTAB Sept. 25, 2014).

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.